Cantata Bio LLC
Worcester, MA Part of Edenroc Sciences, LLC
- UEI
- F4QRHMMF3CC8
- CAGE
- 9FQ41
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Corporate family
-
-
Parent
Worcester, MA
GCJPLLTXJM53
-
Parent
Worcester, MA
GCJPLLTXJM53
- SAM.gov registration date
- Physical address
- 100 Barber Ave, Worcester, MA 01606, USA
- Website
- arcbiocomms.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $46,260 |
| FY2025 | $0 |
| FY2024 | $89,250 |
| FY2023 | $46,525 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $46,260 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Commercialization of a rapid, automated HI-C platform for sensitive genomic profiling of multiple cancer sample types | National Human Genome Research Institute (NIH) | $1,993,708 |
Similar vendors
About the company
Cantata Bio LLC, a small business operating as a limited liability company and subsidiary of Edenroc Sciences LLC, sells genomic library preparation and sequencing services to federal research agencies as a prime contractor under total small business set-asides and competitive designations. Cantata operates from Worcester, Massachusetts (with operations in Santa Cruz, California) and delivers Hi-C, Micro-C, and Omni-C chromatin analysis platforms and deep sequencing services for cancer research, animal health, and plant genetics applications.
Cantata's federal footprint remains nascent but diversified across three customer agencies within the National Institutes of Health and the Department of Agriculture. The National Cancer Institute accounts for two awards totaling $136 thousand in combined potential value, the National Human Genome Research Institute for two awards totaling $32 thousand, and the USDA Agricultural Research Service Northeast Area for two awards totaling $14 thousand — representing 100% coverage across all six prime awards and grants. The company competes exclusively as a prime (100% of awards); no subcontracting footprint is present in the source data.
Recent contract work centers on purchase orders for genomic library preparation and sequencing. A July 2026 NCI total small business set-aside purchase order worth $46.260 thousand covers Dovetail Micro-C library preparation (four libraries for 80X sequencing) and 990 million read pairs with analysis portal credits, completing July 2027. A September 2024 NCI purchase order (no set-aside used) valued at $89.250 thousand procured Cantata Micro-C library preparation services. Two August 2023 USDA-ARS purchase orders, each valued at $7.062 thousand and designated as total small business set-asides, covered Omni-C library preparation for Eimeria acervulina and deep sequencing for Hi-Rise scaffolding projects. A March 2023 National Human Genome Research Institute purchase order worth $32.400 thousand was for Dovetail Micro-C library preparation and epigenetics sequencing.
Cantata also holds a prime federal grant award: a project grant from the National Human Genome Research Institute beginning September 2024 and completing August 2026 for commercialization of VariLink, a rapid, automated Hi-C platform for sensitive genomic profiling of multiple cancer sample types. The source materials indicate this grant project addresses structural variant detection in cancer genomes, enabling detection of large structural variants while maintaining sensitivity to smaller variants (SNVs and indels) and overcoming workflow and cost constraints of existing Hi-C technologies.
Award activity shows two awards in 2023, two in 2024, and one in 2026 (the most recent July 2026), with one award (worth $46 thousand) completing within the next twenty-four months and therefore facing recompete. Combined obligated dollars across all awards reach $2.2 million against a combined potential value of $182 thousand, indicating significant overages on purchase orders. Cantata operates under NAICS Research and Development in the Physical, Engineering, and Life Sciences (three awards) and Testing Laboratories and Services (two awards), positioning the company in biomedical research services and genomic analysis.
Quick answers
Is Cantata Bio LLC registered in SAM.gov?
Yes. Cantata Bio LLC's SAM.gov registration is active through December 26, 2026.
What is Cantata Bio LLC's CAGE code?
Cantata Bio LLC's CAGE code is 9FQ41, and its Unique Entity ID (UEI) is F4QRHMMF3CC8.
How much has Cantata Bio LLC received in federal contracts?
Federal contracts obligated $182,035 to Cantata Bio LLC in fiscal years 2023 through 2027.
What is Cantata Bio LLC's most recent federal award?
Cantata Bio LLC's most recent federal contract award is NCI: dovetail micro-C library prep (4 libs for 80X, product code 2059. 990M read pairs, product code 3018. Dovetail… (75N98026P01120), from Office of Logisitics and Acquisition Operations (NIH), on July 31, 2026.
On GovTribe
See Cantata Bio LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors